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Twist, a Master Regulator of Morphogenesis,
Plays an Essential Role in Tumor Metastasis
Introduction
Tumor metastasis is the most common cause of death
Jing Yang,1,8 Sendurai A. Mani,1,8
Joana Liu Donaher,1 Sridhar Ramaswamy,2,3
Raphael A. Itzykson,4 Christophe Come,5
in cancer patients. In carcinomas, the metastatic pro-Pierre Savagner,5 Inna Gitelman,6
cess is thought to consist of a number of distinct steps.Andrea Richardson,7 and Robert A. Weinberg1,*
The first step—invasion—requires neoplastic epithelial1Whitehead Institute for Biomedical Research
cells to lose cell-cell adhesion and to gain motility, which9 Cambridge Center
enables them to invade the adjacent tissue. During theCambridge, Massachusetts 02142
second step, intravasation, tumor cells penetrate2 Cancer Genomics Program
through the endothelium of blood or lymphatic vesselsBroad Institute
to enter the systemic circulation. Only some circulatingCambridge, Massachusetts 02141
tumor cells appear to be able to survive the passage3 MGH Center for Cancer Research
through circulation. Some of these survivors manage toCharlestown, Massachusetts 02129
complete the next step—extravasation—as they extrav-4 Ecole Normale Superieure
asate through the capillary endothelium at distal sites.75230 Paris Cedex 05
Finally, in the new host environment, an even smallerFrance
subset of such metastasizing cells succeeds in prolifer-5 EMI 0229 INSERM
ating from minute growths (micrometastases) into malig-CRLC Val d’Aurelle-Paul Lamarque
nant, secondary tumors (Fidler, 2003). A central aim in34298 Montpellier Cedex 5
the study of tumor metastasis is to understand the na-France
ture of the distinct genetic and epigenetic changes that6 Department of Molecular Genetics & Development
program these individual steps.Ben Gurion University of the Negev
Recently, our understanding of metastasis has beenBeer Sheva 84105
expanded through microarray analyses of various hu-Israel
man tumor samples. For example, several studies of7 Department of Pathology
human primary breast tumors have generated gene ex-Brigham and Women’s Hospital
pression profiles that are predictive of metastasis orHarvard Medical School
poor survival rate (Ramaswamy et al., 2003; van’t Veer etBoston, Massachusetts 02115
al., 2002). Such analyses are very powerful for producing
fingerprints of metastatic tumor cells, which could be
used as prognostic markers of metastatic diseases.
However, due to the lack of further experimental manip-Summary
ulation of human tumor samples, it has been very difficult
to elucidate the specific contributions of such genes toMetastasis is a multistep process during which cancer
tumor metastasis.cells disseminate from the site of primary tumors and
Experimental animal models have been successfullyestablish secondary tumors in distant organs. In a
used to identify molecular elements during metastasis.search for key regulators of metastasis in a murine
For example, in an expression profile analysis compar-breast tumor model, we have found that the transcrip-
ing melanoma cells and their highly metastatic deriva-tion factor Twist, a master regulator of embryonic mor-
tives, RhoC was identified as essential for pulmonaryphogenesis, plays an essential role in metastasis. Sup-
metastasis by melanoma cells that were injected intra-pression of Twist expression in highly metastatic
venously into mice (Clark et al., 2000). Recently, a setmammary carcinoma cells specifically inhibits their
of genes, including osteopontin and IL-11, were shownability to metastasize from the mammary gland to the
to promote bone metastasis when human breast cancerlung. Ectopic expression of Twist results in loss of
cells were injected via the intracardiac route (Kang etE-cadherin-mediated cell-cell adhesion, activation of
al., 2003). Most of these models rely on the introductionmesenchymal markers, and induction of cell motility,
of tumor cells directly into the systemic circulation. Suchsuggesting that Twist contributes to metastasis by
approaches obviate the steps of invasion and intravasa-promoting an epithelial-mesenchymal transition (EMT).
tion and therefore are unlikely to reveal genes involvedIn human breast cancers, high level of Twist expres-
in these early steps of metastasis.sion is correlated with invasive lobular carcinoma, a
Given the complexity of the process of metastasis, ithighly infiltrating tumor type associated with loss of
is essential to exploit experimental models in which eachE-cadherin expression. These results establish a
of the steps of metastasis is represented and can bemechanistic link between Twist, EMT, and tumor me-
manipulated individually. In this report, we exploit atastasis.
mouse mammary tumor model, in which a set of other-
wise isogenic tumor cell populations is able to complete
distinct steps of metastasis when implanted into the*Correspondence: weinberg@wi.mit.edu
8 These authors contributed equally to this work. mammary glands of BALB/c mice (Aslakson and Miller,
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Figure 1. Microarray Analysis Identified Twist to Be Upregulated during the Metastatic Progression
(A) Schematic representation of the microarray experimental procedure.
(B) Gene expression profile scheme. Three groups of genes are classified based on their gene expression in primary tumors of four cell lines.
(C) The average values of Twist expression in four primary tumors formed by each cell line measured by microarray analysis. Each bar
represents the mean  SEM (standard error of the mean).
(D) The relative levels of Twist mRNA measured by real-time RT-PCR in the 168FANR, 4TO7, and 4T1 cells compared to 67NR cells. Each
bar represents the mean  SEM of the PCRs in triplicate.
(E) Expression of Twist protein was examined by immunoblotting in all four murine cell lines. The HMEC cells overexpressing mouse Twist is
used as a positive control, and -actin is used as a loading control.
1992). We have identified a transcription factor, Twist, Thus, (1) cells of the line 67NR form primary tumors,
but no tumor cells are detectable in any distant tissue,as being essential for tumor metastasis and have char-
including blood, lymph nodes, and lung. (2) Cells of theacterized the molecular actions of Twist and its involve-
168FARN line disseminate from mammary fat pads andment in human breast cancer pathogenesis.
can be detected in lymph nodes; however, 168FARN
cells are rarely detectable in lung, indicating that this cell
Results line is unable to accomplish extravasation effectively. (3)
Cells of the 4TO7 line are able to spread to lung, but
Gene Expression Patterns Associated with cannot establish visible metastatic nodules. Moreover,
Individual Steps of Mammary Tumor Metastasis removal of primary 4TO7 tumors results in the disap-
We utilized a mouse mammary tumor model that con- pearance of clonogenic cells from the lung, suggesting
sists of four distinct tumor cell lines, 67NR, 168FARN, that 4TO7 primary tumors can continuously seed distant
4TO7, and 4T1. All four lines are derived from a single sites, but fail to colonize these sites following their ar-
mammary tumor that arose spontaneously in a wild- rival. (4) Finally, cells of the 4T1 line are able to complete
type BALB/c mouse. When cells from these four cell all steps of metastasis and form visible metastatic nod-
lines are implanted into the mammary fat pads of synge- ules in lung efficiently (Aslakson and Miller, 1992). The
neic BALB/c mice, they form mammary carcinomas behavior of these tumor lines reflects the sequence of
within a month (Aslakson and Miller, 1992). While these multistep metastasis progression. We therefore set out
cell lines form primary tumors with equivalent kinetics, to compare the gene expression profiles of the four
cell lines in order to dissect the specific genetic andthey differ dramatically in their metastatic potential.
An Essential Role of Twist in Tumor Metastasis
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epigenetic changes associated with their respective analysis showed that Twist mRNA was expressed in
168FARN, 4TO7, and 4T1 tumors, but not 67NR tumorsmetastatic abilities.
To compare the gene expression profiles, we injected (Figure 1C). Real-time RT-PCR analysis confirmed that
Twist mRNA was expressed 5–15-fold higher in 168FARN,cells from each of the four lines into the mammary glands
of BALB/c mice (Figure 1A). At 30 days postinjection, 4TO7, and 4T1 tumor cells compared to 67NR cells (Fig-
ure 1D). We also observed that Twist protein was ex-all the cells formed primary tumors weighing 2–3 grams.
We confirmed their respective metastatic phenotypes pressed in the 168FARN, 4TO7, and 4T1 tumor cells,
but not in the 67NR cells (Figure 1E). In addition, weas previously reported (Aslakson and Miller, 1992). We
utilized primary mammary tumors instead of cell lines could not detect the expression of Twist in normal mam-
mary epithelial cells, such as mouse EPH4 cells (datagrowing in vitro for microarray analysis, because the
host tissue environment can drastically influence their not shown) and immortalized human mammary epithelial
cells (HMECs) (Figure 5C), indicating that Twist expres-metastatic abilities and their gene expression profiles.
In addition, histological analyses revealed that, in each sion is specifically induced in 168FARN, 4TO7, and 4T1
tumor cells. These observations led us to pursue Twistcase, major components of the tumor samples (95%)
were descendants of the introduced tumor cells with as an attractive candidate for orchestrating some steps
of metastasis in this mammary tumor model.minimum host stromal contribution.
We hypothesized that each of the defined metastatic Our interest in Twist was further enhanced by its
known functions as a master regulator of embryonicproperties exhibited by these four tumor lines results
from alterations in the expression of a specific group of morphogenesis. Twist was originally identified as a key
inducer of mesoderm formation in Drosophila (Thissegenes. Accordingly, a group of genes involved in inva-
sion and intravasation (Group X) should be altered in et al., 1987). In mice, Twist is essential for proper cell
migration and localization during cranial neural tubethe 168FARN, 4TO7, and 4T1 cells, but not in the 67NR
cells. Similarly, a set of genes altered in 4TO7 and 4T1 morphogenesis (Chen and Behringer, 1995; Soo et al.,
2002). Across phyla, Twist plays a major role in inducingcells compared to 67NR and 168FARN cells (Group Y)
are thought to enable these tumor cells to extravasate cell movement and tissue reorganization during specific
steps of embryonic development (Castanon and Baylies,into distant sites. Finally, the Group Z genes are those
that are specifically altered in the 4T1 cells compared 2002). Such cell migration and tissue remodeling also
occurs during tumor invasion and metastasis. Therefore,to the other three lines, and are expected to be responsi-
ble for the ability of 4T1 cell to form visible metastatic we speculated that Twist expression might be dere-
pressed during tumor progression. Given the complexnodules in the lung (Figure 1B). We compared the tran-
scription profile of the four tumor lines and assigned nature of the multistep metastasis process, Twist, as a
key transcription factor controlling morphogenesis, maydifferentially expressed genes (changes greater than
2.5-fold) to such three groups. The Group X genes con- be able to elicit multiple biochemical and cell biological
alterations of metastasis.sisted of 36 upregulated genes and 9 downregulated
genes. The Group Y genes included 7 upregulated and
3 downregulated genes. The genes in the Group Z con-
Twist Is Essential for Tumor Metastasistain 38 upregulated genes and 59 downregulated genes
from the Mammary Gland to the Lung(Supplemental Data available at http://www.cell.com/
To determine whether Twist plays a causal role in tumorcgi/content/full/117/7/927/DC1).
metastasis, we tested whether inhibition of Twist ex-Among the identified genes, several had previously
pression in the highly metastatic 4T1 cells would affectbeen implicated in metastasis. For example, we identi-
their metastatic ability. To do so, we chose several se-fied the CXCR3 chemokine receptor as a Group X gene.
quences in the coding region of the mouse Twist geneIn fact, several members of the CXCR chemokine recep-
and designed short hairpin-interfering RNAs (siRNA) tar-tor family are highly expressed in malignant human
geted against each sequence. To test whether thesebreast cancers and melanomas and can elicit chemotac-
siRNAs could suppress Twist expression in 4T1 cells,tic and invasive responses (Muller et al., 2001). In addi-
we infected these cells with the lentiviral vector trans-tion, the matrix metalloproteinases MMP9, which plays
ducing a DNA segment specifying such siRNA se-key roles in tumor invasion and metastasis (Egeblad and
quences and then selected the cells stably expressingWerb, 2002), were assigned to Group Z. These results
the siRNAs. As shown in Figure 2A, expression of allindicated that in this mammary tumor metastasis model,
three siRNAs drastically reduced the expression of Twisttumor cells employ several known pathways of metasta-
protein in 4T1 cells. Specifically, the Twist siRNA3 sup-sis. Moreover, successful identification of these genes
pressed the expression of Twist protein to a level thatvalidated our approach to identify novel genes that may
was undetectable by immunoblotting (Figure 2A). Anplay equally important roles in metastasis.
siRNA, whose sequence did not match any known mouse
gene, was also introduced into 4T1 cells. As anticipated,
this control siRNA did not cause a reduction of TwistIncreased Expression of Twist Correlates
with Tumor Invasion and Metastasis expression (Figure 2A).
We examined whether loss of Twist expression affectsAmong the identified genes, the transcription factor
Twist stood out as an attractive candidate for modulat- 4T1 cells to proliferate in vitro and form primary tumors
in vivo. 4T1 cells carrying either Twist-siRNA3 or control-ing metastasis. Twist was the second most strongly
upregulated gene in the Group X list. The microarray siRNA grew at similar rates in vitro (Figure 2B), indicating
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weights of the resulting primary tumors weekly. 4T1 cells
carrying either Twist-siRNA3 or the control-siRNA formed
primary mammary tumors at identical rates (Figure 2C).
These results demonstrated that Twist is not required
for primary tumor formation by 4T1 cells.
To find out whether Twist expression continued to be
suppressed by siRNA in tumors growing in mice, we
collected primary tumors formed by either the 4T1 Twist-
siRNA3 cells or the 4T1 control-siRNA cells and propa-
gated the tumor cells in the presence of puromycin. We
observed that expression of Twist in 4T1 cells continued
to be suppressed by Twist-siRNA one month after tumor
implantation (Figure 3E).
To determine whether loss of Twist expression af-
fected the ability of 4T1 cells to metastasize, we first
examined the metastatic behaviors of the 4T1 tumor
cells expressing either Twist-siRNA3 or the control-
siRNA. Four weeks after implantation of such cells in
the mammary glands of BALB/c mice, we sacrificed
the mice and examined lungs for metastatic lesions by
inspection under a dissection microscope. While tumors
expressing control-siRNA formed large numbers of
macroscopically visible metastases in their lungs, those
that expressed Twist-siRNA3 formed very few metasta-
ses (Figure 3A). The average number of visible meta-
static nodules dropped from 105  14 per lung in mice
carrying 4T1 control-siRNA tumors to 14  2 nodules
per lung in mice carrying 4T1 Twist-siRNA3 tumors (Fig-
ure 3B). Histological analyses confirmed that the number
of micrometastatic lesions was also drastically reduced
in the lungs of mice carrying 4T1 Twist-siRNA3 tumors
(Figure 3C). In addition, the sizes of individual metastatic
nodules present in the lungs of both groups of mice
were very similar. These results suggested that loss
of Twist expression reduced the number of metastatic
nodules present in the lung, rather than preventing mi-
crometastases established in the lung from proliferating
into visible nodules.
To exclude the possibility that the observed effect is
due to nonspecific suppression of off-target genes by
Twist siRNA-3, we further tested whether two additional
Twist siRNA sequences (Twist siRNA5 and Twist
siRNA7) can also suppress the ability of 4T1 cells to
metastasize. Indeed, expression of either Twist siRNA5
or siRNA7 in 4T1 tumor cells also drastically reduced
the formation of pulmonary metastatic nodules by 4T1
tumors in mice (Figure 3D). Together, these results dem-
Figure 2. Suppression of Twist Expression by Stable siRNA Does onstrate that continued Twist expression is essential
Not Affect the Proliferation of 4T1 Cells In Vitro and In Vivo for efficient execution of the metastatic program of the
(A) Expression of Twist protein was examined by immunoblotting 4T1 cells.
in 4T1 cells stably expressing control-siRNA, Twist-siRNA3, Twist-
We suspected that the presence of small numbers ofsiRNA5, or Twist-siRNA7.
nodules in the lungs of mice carrying 4T1 Twist-siRNAs(B) Population doublings of the 4T1 cells expressing either control-
siRNA or Twist-siRNA3. Each data point represents the mean  tumors might be caused by incomplete suppression of
SEM number of cells counted in triplicate dishes. Twist by siRNA in these polyclonal populations. This is
(C) Growth patterns of primary mammary tumors formed by 4T1 due to variable numbers of integrated, siRNA-express-
cells expressing either control-siRNA or Twist-siRNA3. Each data
ing proviral vectors generated by lentiviral infection inpoint represents the mean  SEM of ten primary tumors.
individual cells. Therefore, we analyzed the expression
of Twist in the 4T1 Twist-siRNA3 and 4T1 control-siRNA
tumor cells recovered from the lung samples. As shown
in Figure 3E, the 4T1 Twist-siRNA3 tumor cells isolatedthat Twist is not required for the proliferation of 4T1
from lungs continue to express a far lower level of Twistcells in culture. We then injected such cells into the
mammary fat pads of BALB/c mice and measured the protein than did the 4T1 control-siRNA cells isolated
An Essential Role of Twist in Tumor Metastasis
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Figure 3. Suppression of Twist Expression Inhibited the Ability of 4T1 Cells to Metastasize from the Mammary Gland to Lung
(A) Representative photos of the lungs from mice carrying mammary tumors of 4T1 control-siRNA cells or 4T1 Twist-siRNA3 cells 30 days
post tumor implantation. The arrows point to the metastatic nodules in the lung.
(B) Total numbers of lung metastatic nodules in individual mice were counted under the dissection scope. Two populations of 4T1 cells
infected independently with Twist-siRNA3 lentivirus were used in four independent experiments (15–20 mice per experiment) and consistently
yielded similar results.
(C) Representative H&E staining sections of the lungs from Figure 3A. N, lung tissue; M, metastatic nodule.
(D) Total numbers of metastatic nodules in the lung of individual mice carrying mammary tumors of 4T1 control-siRNA cells, 4T1 Twist-siRNA5
cells or 4T1 Twist-siRNA 7 cells at 28 days post tumor implantation.
(E) Expression of Twist protein was examined by immunoblotting of tumor cells recovered from both primary tumors and lungs of individual
mice carrying either 4T1 control-siRNA tumors or 4T1 Twist-siRNA3 tumors. -actin is used as a loading control.
from lungs. However, in many samples of 4T1 Twist- ical examinations showed that the primary tumors
formed by the 4T1 Twist-siRNA cells and the 4T1 control-siRNA3 tumor cells recovered from lungs, low, but signif-
icant levels of Twist expression were detectable. In con- siRNA cells were both undifferentiated mammary carci-
nomas (Figure 4A). To examine the ability of 4T1 Twist-trast, expression of Twist was undetectable in the 4T1
Twist-siRNA3 cells isolated from primary tumors (Figure siRNA cells to intravasate, we cultured blood samples
from mice carrying primary tumors derived from 4T13E). These data argue that incomplete suppression of
Twist by siRNA in a small subset of 4T1 Twist-siRNA Twist-siRNA3 cells or 4T1 control-siRNA cells. The colo-
nies formed by these cells were quantified to determinecells account for the residual ability of such cells to form
lung metastases. the number of 4T1 tumor cells present in such blood
samples. We recovered colony-forming cells from the
blood samples of 7 out of 9 mice bearing 4T1 control-Suppression of Twist Expression Reduces
the Presence of Tumor Cells siRNA tumors. In contrast, colonies were recovered from
only 2 out of 9 mice bearing 4T1 Twist-siRNA3 tumorsin the Blood Circulation
We attempted to determine the specific steps of the (Figure 4B). The average number of colonies recovered
from the blood of the two mice bearing 4T1 Twist–metastatic process to which Twist contributes. Histolog-
Cell
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Figure 4. Suppression of Twist Expression Reduced the Presence of 4T1 Cells in the Blood Circulation
(A) Representative H&E staining sections of the primary mammary tumors formed by 4T1 control-siRNA cells or 4T1 Twist-siRNA3 cells. The
large white cells are fat cells in mouse mammary glands.
(B) Total numbers of colonies formed by tumor cells presented in 150 l blood from mice carrying mammary tumors of 4T1 control-siRNA
cells or 4T1 Twist-siRNA3 cells.
(C) Anchorage-independent growth of 4T1 control-siRNA cells or 4T1 Twist-siRNA3 cells. 1  103 or 2  102 cells were seeded, and the
number of soft agar colonies presented is the mean of colony counts in ten 40 microscopic fields from two dishes.
(D) Representative photos of soft agar colonies formed by 4T1 control-siRNA cells or 4T1 Twist-siRNA3 cells.
siRNA3 tumors (8 colonies/150 l blood) were much tage of the known actions of this transcription factor
during mesoderm formation in Drosophila. At gastrula-smaller than those recovered from the seven mice bear-
ing 4T1 control-siRNA tumors (21 colonies/150l blood) tion, Twist is induced to allow ventral furrow cells to
migrate and form the mesodermal layer (Leptin and Gru-(Figure 4B). This observation suggests that expression
of Twist in 4T1 cells enables continuous presence of newald, 1990). During this process, these cells lose cell-
cell adhesion and undergo an epithelial-mesenchymalthese tumor cells in the blood.
The presence of 4T1 cells in the circulation indicates transition (EMT) (Hay, 1995). Such EMT is suggested to
contribute to the dissemination of carcinoma cells fromthat 4T1 cells are able to complete intravasation and to
survive anoikis due to loss of cell-matrix attachment. epithelial tumors (Thiery, 2002). We therefore speculated
that the contribution of Twist to tumor metastasis mightWe tested whether Twist is required for 4T1 cells to
survive and proliferate in an anchorage-independent involve the induction of an EMT and cell motility.
We examined whether expression of Twist was ablemanner. After growing in soft agar for 15 days, 4T1 cells
carrying either Twist siRNA3 or the control siRNA formed to promote an EMT in normal mammalian cells. To do
so, we expressed Twist by retroviral infection in MDCKvery similar numbers of colonies (Figure 4C), and these
colonies were of comparable size (Figure 4D). This result kidney epithelial cells. As shown in Figure 5A, MDCK
cells maintain highly organized cell-cell adhesion andsuggested that Twist does not necessarily affect the
survival of 4T1 cells in the circulation; rather, Twist ap- cell polarity; expression of Twist in these cells led to
loss of cell-cell contacts and cell scattering. The cobble-pears to allow the step of intravasation. The involvement
of Twist in intravasation is further supported by our stone-like appearance of these epithelial cells was re-
placed by a spindle-like, fibroblastic morphology (Figureabove observation that loss of Twist reduced the num-
ber of micrometastases in the lung, suggesting expres- 5A). This morphological change represents one of the
hallmarks of an EMT. To determine whether the molecu-sion of Twist is necessary for 4T1 cells to leave their
primary tumor and to reach the lung. lar alterations of an EMT occurred in these cells, we
examined the localization of several adherens junction
proteins, such as E-cadherin, -catenin, -catenin, andTwist Induces an Epithelial-Mesenchymal
Transition (EMT) and Cell Migration -catenin. Immunostaining showed that all four proteins
disappeared from cell membrane in the Twist-express-To understand the specific biological functions that
Twist exerts during tumor metastasis, we took advan- ing MDCK cells compared to their strong membrane
An Essential Role of Twist in Tumor Metastasis
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Figure 5. Twist Induces an EMT and Cell Migration
(A) The morphologies of the MDCK cells and HMEC cells expressing either the control vector pBabe-PURO or pBabe-PURO/Twist were
revealed by phase contrast microscopy.
(B) Immunofluorescence staining of E-cadherin, -catenin, -catenin, fibronectin,n and vimentin in the MDCK cells expressing either pBabe-
PURO or pBabe-PURO/Twist. The green signal represents the staining of corresponding protein, and the blue signal represents the nuclear
DNA staining by Hoechst.
(C) Expression of epithelial proteins, including E-cadherin, -catenin, -catenin, and -catenin, and mesenchymal proteins, including fibronectin,
vimentin, N-cadherin, and smooth muscle actin was examined by immunoblotting in the MDCK cells and HMEC cells expressing either pBabe-
PURO or pBabe-PURO/Twist. -actin is used as a loading control.
(D) MDCK cells and HMEC cells expressing either pBabe-PURO or pBabe-PURO/Twist were induced to migrate toward serum (MDCK cells)
or growth factors (HMEC cells). The migration toward growth factor-free media was examined as negative control for each cell line. The
migration ability is presented as percentage of migrating cells over the total cells in the chamber. Each bar represents the mean  SEM of
samples measured in triplicate.
Cell
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staining in the control cells (Figure 5B). We also ob-
served complete loss of E-cadherin, -catenin, and
-catenin proteins by immunoblotting (Figure 5C). In
contrast, the expression of fibroblast markers, including
fibronectin, vimentin, smooth-muscle actin, and N-cad-
herin, whose expression has been shown to correlate
positively with the EMT (Boyer and Thiery, 1993), was
strongly induced (Figures 5B and 5C). Hence, both the
morphological and molecular changes in the Twist-
expressing MDCK cells demonstrated that these cells
had undergone an EMT.
We wished to determine whether the ability of Twist
to induce an EMT in MDCK cells could be extended to
epithelial cells more relevant to breast cancers. Accord-
ingly, we introduced Twist into immortalized human
mammary epithelial cells (HMECs) (Elenbaas et al.,
2001). We observed the identical set of changes associ-
ated with EMT in these cells (Figures 5A and 5C). Fur-
thermore, both MDCK and HMEC cells expressing Twist,
but not control cells, exhibited high levels of growth
factor-induced directional migration (Figure 5D). Taken
together, these data indicated that Twist is capable of
inducing an EMT and associated migratory behavior in
normal epithelial cells and suggested that Twist-induced
EMT could contribute to the phenotypes of invasion
and metastasis.
Loss of E-cadherin appears to be critical to an EMT.
One major mechanism for inhibiting E-cadherin expres-
sion involves silencing of E-cadherin transcription
through three E-boxes in its promoter (Thiery, 2002).
We observed an over 100-fold reduction of E-cadherin
mRNA level in HMEC cells expressing Twist (Figure
6A). To test whether this transcriptional repression is
achieved through the three E-boxes in the E-cadherin
promoter, we transiently transfected HMEC-Twist cells
with a reporter construct containing the luciferase gene
(Luc) under the control of the human E-cadherin pro-
moter (Hajra et al., 2002). Indeed, Luc activity was effi-
ciently suppressed in the HMEC-Twist cells compared
to the HMEC-control cells. A similar degree of repression
was also observed in the HMEC cells expressing Snail,
a known repressor of E-cadherin expression (Figure 6B).
When we introduced two Luc reporter constructs in
which the E-box elements had been mutated (Hajra et
Figure 6. Expression of Twist Results in Repression of E-Cadh-
al., 2002), the Luc activities were derepressed in the
HMEC cells expressing Twist (Figure 6B). These data
indicate that Twist directly or indirectly causes the tran-
scriptional repression of E-cadherin through the E-boxerin Transcription
elements on the E-cadherin promoter.(A) The endogenous levels of E-cadherin mRNA was measured by
real-time RT-PCR in the HMEC cells expressing either pBabe-PURO To understand whether suppression of E-cadherin ex-
or pBabe-PURO/Twist. The level of E-cadherin mRNA in MCF7 cells pression is the sole cause of the Twist-induced EMT,
is used as a positive control. Each bar represents the mean  SEM we examined whether ectopic expression of E-cadherin
of the PCR reactions in triplicate.
could revert the EMT phenotypes in HMEC-Twist cells.(B) The luciferase activity under the control of various human
While the level of E-cadherin protein was restored to aE-cadherin promoter constructs were measured in the HMEC cells
similar level as seen in the parental HMEC cells, theexpressing either pBabe-PURO, pBabe-PURO/Twist, or Snail.
Ecad(-108)-Luc is the wild-type E-cadherin promoter construct; HMEC-Twist cells expressing exogenous E-cadherin re-
Ecad(108)/EboxA/EboxB/EboxC.MUT-Luc is the E-cadherin pro- tained their spindle-like, fibroblastic morphology (Figure
moter construct where consensus EboxA, EboxB, and EboxC were
mutated; Ecad(108)/EboxC.MUT-Luc is the E-cadherin promoter
construct where consensus EboxC was mutated. Each bar repre-
sents the mean  SEM of three experiments.
(C) Morphologies of the HMEC-Twist cells expressing either pBabe- or pBabe-Zeo/E-cadherin. The parental HMECs were used as a
Zeo or pBabe-Zeo/E-cadherin. positive control for E-cadherin expression. Expression of epithelial
(D) Expression of exogenous E-cadherin was examined in the protein -catenin and mesenchymal proteins, fibronectin, and vi-
HMEC-Twist cells expressing either the control vector pBabe-Zeo mentin was also examined. -actin is used as a loading control.
An Essential Role of Twist in Tumor Metastasis
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Figure 7. Expression of Twist in Human Tumor Cell Lines and in Human Breast Carcinomas
(A) Expression of Twist mRNA in a panel of human nonmetastatic or metastatic cell lines was examined by RT-PCR. The endogenous GAPDH
mRNA level was measured as the internal control.
(B) Gene cluster analysis of 54 human invasive breast carcinoma samples using four genes: Twist, E-cadherin, fibronectin, and vimentin. For
each gene, the average signal among all tumor samples is used as the baseline (1-fold).
(C) The relative levels of Twist expression in individual normal breast or tumor samples are plotted into three groups by their tumor types
(open circle). Each bar represents the mean  SEM of each group (solid strike). The difference of Twist expression between invasive ductal
carcinoma and invasive lobular carcinoma has p-value 	 0.021 based on two-tail Student’s T-test.
(D) The relative levels of E-cadherin expression in individual normal breast or tumor samples were plotted into three groups by their tumor
types (open circle). Each bar represents the mean  SEM of each group (solid strike). The difference of E-cadherin expression between
invasive ductal carcinoma and invasive lobular carcinoma has p-value 	 0.008 based on two-tail Student’s T-test.
6C). In addition, these cells continued to express fibro- cinoma, mixed ductal/lobular type, and lobular carci-
noma (Signoretti et al., 2002). The high Twist expressionblastic markers, such as vimentin and fibronectin (Figure
6C). This result demonstrates that in addition to E-cad- clustered around the group of invasive lobular carcino-
mas (ILC). About 70% invasive lobular carcinomasherin, Twist also modulates expression of additional im-
portant targets to promote an EMT. showed elevated Twist expression. In contrast, a far
smaller proportion of invasive ductal carcinomas (32%)
(IDC) and mixed ductal/lobular carcinomas (30%) had
Expression of Twist mRNA in Human Breast elevated Twist expression (Figure 7A). Moreover, most
Tumor Samples normal breast tissue samples did not show elevated
We wished to determine whether Twist expression was Twist expression (Figure 7B), and cultured human mam-
detectable in human breast tumors, in which it might mary epithelial cells do not express any detectable level
play a role in the invasive or metastatic phenotypes. of Twist (Figure 5C).
We observed that Twist was expressed in several inva- In fact, invasive lobular carcinoma displays many fea-
sive and metastatic human tumor cell lines, such as tures of cells that have undergone an EMT. It is defined
SUM1315, MDA-MB 231, and MDA-MB-435. In contrast, histologically by its diffusely infiltrative growth, which
nonmetastatic tumor cell lines, such as MCF7 and BT20, constitutes dyshesive single tumor cells or single-file
did not express Twist (Figure 7A). rows of cells. These characteristics are distinct from
We then determined whether expression of Twist cor- invasive ductal carcinomas, which normally maintain ir-
relates with certain pathological phenotypes in clinical regular mammary tubules and solid sheets of carcinoma
breast tumor samples. To do so, we analyzed a microar- cells. One unique molecular feature of invasive lobular
ray gene expression data set from 57 invasive human carcinomas is their almost universal loss of E-cadherin
expression, whereas only 50% of invasive ductal carci-breast tumors of three subtypes, specifically ductal car-
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noma have reduced expression of E-cadherin (Acs et of E-cadherin expression is a critical event of EMT. Inter-
al., 2001; Gamallo et al., 1993; Moll et al., 1993). Indeed, estingly, in Drosophila Twist can induce the expression
90% of invasive lobular carcinoma samples in our tumor of Snail, a known repressor of E-cadherin transcription
set showed no expression of E-cadherin (Figure 7A). (Ip et al., 1992). However, in spite of repeated attempts,
When the levels of Twist and E-cadherin expression in we could not observe an induction of Snail in the human
the ductal group and the lobular group were compared, mammary epithelial cells that have undergone an EMT
we observed a statistically significant higher level of upon Twist expression (J.Y., A.S. Shieh, and R.A.W.,
Twist transcript in the lobular group (p 	 0.021) (Figure unpublished data). This observation is consistent with
7C). Moreover, we detected a significant loss of E-cad- the notion that Twist and Snail function independently
herin expression in the lobular group in comparison with in mice (Soo et al., 2002; Carver et al., 2001). It is also
the ductal group (p 	 0.008) (Figure 7D). This inverse possible that Twist, acting as a bHLH transcription fac-
correlation between high Twist expression and low tor, binds directly to the E-boxes on the E-cadherin
E-cadherin expression in human invasive lobular carci- promoter to suppress its transcription.
noma is consistent with our finding that Twist can induce In addition to silencing E-cadherin transcription, we
loss of E-cadherin-mediated cell-cell adhesion in epithe- have also found that Twist induces the expression of
lial cells. It also suggests that expression of Twist can mesenchymal markers, such as fibronectin and N-cad-
contribute to the pathogenesis of human invasive lobu- herin, during an EMT. These events appear to be inde-
lar carcinomas. pendent of E-cadherin expression, because we have
found that ectopic expression of E-cadherin could not
revert the EMT phenotype in Twist-expressing HMEC
Discussion cells. Hence, Twist does not rely on E-cadherin repres-
sion to induce mesoderm-specific genes and may, as
Activation of Twist in Tumor Metastasis is the case during Drosophila gastrulation (Leptin, 1991),
The present study utilized gene expression array analy- function as a potent transcriptional activator to induce
ses to identify genes involved in metastasis in a mouse such genes.
mammary tumor model. Twist, a transcription factor im-
portant in embryonic development, was identified to be
essential for the metastatic process. We have demon- Involvement of Twist in Human Cancers
strated that Twist induces loss of E-cadherin-mediated
The experimental model that we used here, implantation
cell-cell adhesion and an EMT in epithelial cells. In hu-
of tumor cells in an orthotopic site in a syngeneic host,
man invasive lobular carcinomas, we also observed an
recapitulates many biological conditions in cancer pa-inverse correlation between the expression levels of
tients. For example, the host tissue environment of pri-Twist and E-cadherin. Together, the present evidence
mary tumors strongly affects their ability to metastasizeleads us to propose that activation of Twist and Twist-
and the target organ sites to which they spread (Gohjiinduced EMT are important components of tumor me-
et al., 1997). Thus, we implanted mammary tumor cellstastasis.
in their orthotopic site—the mammary fat pad. The hostThe metastasis program is a complex series of biologi-
immune system is also thought to play important rolescal steps, thus tumor cells must acquire a series of traits
in tumorigenesis and metastasis (Miller, 1993). In thisthat enable them to overcome multiple barriers erected
study, the tumor cells proliferated in a wild-type BALB/cby the normal tissues that they encounter en route. Our
mouse, so we could examine their metastatic behaviorsresults suggest that during the development of the meta-
in an intact immune environment.static phenotype, tumor cells activate latent morphoge-
Interestingly, we have found a statistically significantnetic programs that are normally active in early develop-
correlation between expression of Twist and invasivement in order to acquire the ability to execute multiple
lobular carcinoma. This observation is also supportedsteps in the metastasis process. By exploiting these
by an independent study of promoter methylation ofgenes and their downstream pleiotropic regulatory pro-
Twist gene in human breast cancers (Fackler et al.,gram, cancer cells can concomitantly acquire many of
2003). This study showed that the promoter of Twistthe traits that are needed for them to invade and metas-
gene was much less frequently methylated in invasivetasize. A number of genes have been identified to partici-
lobular carcinomas as compared to invasive ductal car-pate in the Twist signaling pathway in Drosophila (Fur-
cinomas, indicating that Twist expression is preferen-long et al., 2001). This suggests the possibility that not
tially suppressed in ductal carcinomas.only Twist, but also other molecular components of the
In lobular carcinoma, an important molecular mecha-Twist-associated morphogenesis pathways, are good
nism determining its histologic phenotype is thoughtcandidates to be examined for their possible involve-
to be loss of E-cadherin-mediated cell-cell adhesions.ments in tumor metastasis.
Several means of silencing E-cadherin gene expression
in lobular carcinoma have been observed, including
E-cadherin gene truncation mutations, loss of heterozy-Biological Activities of Twist in EMT
gosity (LOH) of the E-cadherin locus, and methylationThe complex morphological changes observed during
of the E-cadherin promoter (Berx et al., 1996; HuipingTwist-induced EMT raise the question of the identities
et al., 1999; Droufakou et al., 2001). However, theseof the transcriptional targets of Twist. Our observation
mechanisms seem to account for only a portion of thethat E-cadherin transcription is repressed during Twist-
induced EMT is consistent with the hypothesis that loss E-cadherin-negative invasive lobular carcinomas. Our
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ally. Mice were bled from retroorbital sinus, and 150 l blood sam-observation that Twist expression is associated with
ples are cultured in the presence of puromycin. The tumor coloniesinvasive lobular carcinoma provides the first indication
were counted three weeks later. Tumors or lungs were minced andthat repression of the E-cadherin promoter by such tran-
digested in DME-10 with 1 mg/ml collagenase A for 2 hr at 37
C.
scription factors plays a role in pathogenesis of these The tissue mixtures were dispersed with an 18-gauge needle,
tumors. washed, and plated in DME-10 media plus puromycin.
The involvement of Twist in infiltrative sub-types of
carcinomas has also been observed in gastric cancers.
Microarray Hybridization, Data Collection, and Analysis
Twist was found to be significantly upregulated in the 10 g of total RNA from each tumor were used for microarray probe
diffuse-type gastric carcinomas when compared to the synthesis and hybridization as described in Affymetrix GeneChip
manual. For each cell line, four tumors grown individually in fourintestinal-type of gastric carcinomas (Rosivatz et al.,
mice were hybridized to mouse U74A chips. The data collection2002). Provocatively, the diffuse-type gastric carcinoma
was carried out using the Affymetrix GeneChip 3.1. Scaling wasis also characterized pathologically by its infiltrative
performed on the expression data set to minimize global differencesgrowth and is associated with loss of E-cadherin. To-
in mean intensities among individual chips. Expression values below
gether with our results, these studies further suggest baseline (20) were set to 20. To find genes associated with individual
that Twist is likely to repress E-cadherin expression and metastatic phenotypes, we compared the gene expression profiles
promote infiltrative tumor growth in various human car- between each two sets of tumors. For each gene, three statistical
analysis criteria were used to evaluate whether the expression differ-cinomas. Moreover, they suggest that many such EMT-
ence is significant. (1) The difference between two mean expressioninducing transcription factors may be exploited oppor-
values had to be 2-fold over their combined standard deviation;tunistically by different types of human carcinomas in
(2) The fold difference between two mean expression values had to
order to acquire invasive and metastatic powers. be 2.5-fold; (3) The higher mean expression value between two
values had to be 300 because most of the values below 300 were
Experimental Procedures given ABSENT calls by the Affymetrix GeneChip program. Then we
further grouped the resulting differentially expressed genes into the
Cell Cultures
three Groups X, Y, and Z.
67NR, 168FARN, 4TO7, and 4T1 cell lines were provided by Dr.
The gene cluster analysis of human invasive breast tumor samples
Fred R. Miller at Wayne State University and cultured as described
was performed using dChip software as previously described (Sig-
(Aslakson and Miller, 1992). The human mammary epithelial cell line
noretti et al., 2002).
was described previously (Elenbaas et al., 2001). To measure cell
growth rates, cells were seeded at 5 104 per 100-mm dish. For each
cell line, cells from three dishes were trypsinized and counted daily. SYBR-Green Real-Time RT-PCR
Mouse Twist RT-PCR forward primer is CGGGTCATGGCTAACGTG,
Plasmids and its RT-PCR reverse primer is CAGCTTGCCATCTTGGAGTC. Hu-
The mouse Twist cDNA was provided by Dr. Fabienne Perrin- man Twist RT-PCR forward primer is GGAGTCCGCAGTCTTACGAG,
Schmitt at Universite Louis Pasteur and subcloned into the pBabe- and its RT-PCR reverse primer is TCTGGAGGACCTGGTAGAGG.
Puro vector. The siRNA-expressing U6 lentivirus system was pro- Mouse and human GAPDH RT-PCR forward primer is GACCCCTT
vided by Dr. Richard Iggo at Swiss Institute for Experimental Cancer CATTGACCTCAAC, and its RT-PCR reverse primer is CTTCTCCAT
Research (Bridge et al., 2003). Three siRNA-coding oligos against GGTGGTGAAGA.
mouse Twist were designed and verified to be specific to Twist by Total RNA was extracted using RNeasy Mini kit coupled with
Blast search against the mouse genome. Twist-siRNA3-targetting RNase-free DNase set (Qiagen) and reverse transcribed with Hexa-
sequence is AAGCTGAGCAAGATTCAGACC; Twist-siRNA5-tar- nucleotide Mix (Roche). The resulting cDNAs were used for PCR
getting sequence is AGGTACATCGACTTCCTGTAC; and Twist- using SYBR-Green Master PCR mix (Applied Biosystem) in tripli-
siRNA7-targetting sequence is AGCGGGTCATGGCTAACGTGC. cates. PCR and data collection were performed on iCycler (BioRad).
The U6 promoter with Twist-siRNA3, Twist-siRNA5, or Twist-siRNA7 All quantitations were normalized to an endogenous control GAPDH.
insert were subcloned into pSP108-PURO. A control siRNA oligo, The relative quantitation value for each target gene compared to
which does not match any known mouse coding cDNA, was used the calibrator for that target is expressed as 2-(Ct-Cc) (Ct and Cc are
as control. the mean threshold cycle differences after normalizing to GAPDH).
Luciferase reporter gene constructs containing the E-cadherin The relative expression levels of samples are presented by a semi-
promoter sequence and various E-box mutant forms (EboxC.MUT, log plot.
EboxABC.MUT) were provided by Dr. Eric Fearon at University
of Michigan (Hajra et al., 2002).
Antibodies, Immunoblotting, Immunofluorescence,The mouse E-cadherin cDNA was provided by Dr. Gerhard
and HistologyChristofori at University of Basel and subcloned into the pBabe-
Zeo vector. Monoclonal Twist antibody was originally report by Gitelman (1997).
The other antibodies utilized were -actin (Abcam), E-cadherin,
Viral Production and Infection of Target Cells -catenin, -catenin, -catenin, Fibronectin and N-cadherin (BD
The production of lentiviruses and pBabe-amphotropic viruses, and Transduction), vimentin V9 (NeoMarkers), and smooth muscle actin
infection of target cells were described previously (Stewart et al., (Sigma). All procedures were performed as described (Elenbaas et
2003). The 4T1 cells were selected with 12 g/ml puromycin. The al., 2001).
HMEC cells were selected with 2 g/ml puromycin, or 200 g/ml
Zeocin. The MDCK cells were selected with 4 g/ml puormycin.
Assay of Anchorage-Independent Growth
The soft agar assay was performed as described (Elenbaas et al.,Mice and Mammary Gland Injection
2001).Female BALB/cJ mice, 3–5 months, from Jackson Laboratory were
used for surgery. Mice were anesthetized with 2,2,2-tribromoetha-
nol. The skin was incised and tumor cells (5  105) in a 20 l DME- Migration Assay
10 were injected into the mammary gland. This assay was performed as described (Clark et al., 2000).
Measurement of Primary Tumor Growth and Isolation
Luciferase Reporter Assayof Tumors Cells from the Mammary Gland, Blood, and Lung
Cells of 50% confluence in 12-well dishes were transfected usingPost tumor cell injection, groups of 5–10 mice were sacrificed
weekly. The mammary tumors were removed and weighed individu- Fugene6 (Roche). 0.2 g E-cadherin reporter gene construct and
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0.2 ng of pRL-SV40 (Promega) were cotransfected per well. Cell Elenbaas, B., Spirio, L., Koerner, F., Fleming, M.D., Zimonjic, D.B.,
Donaher, J.L., Popescu, N.C., Hahn, W.C., and Weinberg, R.A.extracts were prepared 40 hr after transfection, and the luciferase
activity was measured using the Dual-Luciferase Reporter Assay (2001). Human breast cancer cells generated by oncogenic transfor-
mation of primary mammary epithelial cells. Genes Dev. 15, 50–65.System (Promega). All experiments were performed in triplicates.
Fackler, M.J., McVeigh, M., Evron, E., Garrett, E., Mehrotra, J., Pol-
yak, K., Sukumar, S., and Argani, P. (2003). DNA methylation ofAcknowledgments
RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and
invasive lobular breast carcinoma. Int. J. Cancer 107, 970–975.We thank F. Miller, F. Perrin-Schmitt, R. Iggo, E. Fearon, and G.
Christofori for reagents; I. Ben-Porath, S. Stewart, U. Muller, K. Fidler, I.J. (2003). The pathogenesis of cancer metastasis: the ‘seed
Hartwell, and other members of R.A.W.’s laboratory for critical re- and soil’ hypothesis revisited. Nat. Rev. Cancer 3, 453–458.
view of the manuscript; F. Reinhardt, M. Brooks, and C. Ladd for
Furlong, E.E., Andersen, E.C., Null, B., White, K.P., and Scott, M.P.technical help; J. Staunton and Z. Wang for advice on statistical
(2001). Patterns of gene expression during Drosophila mesodermanalysis. We acknowledge the support of Whitehead Institute Func-
development. Science 293, 1629–1633.tional Genomic Program (consortium partners including Affymetrix,
Millennium, and Bristol-Mayers Squibb) and W.M. Keck Biological Gamallo, C., Palacios, J., Suarez, A., Pizarro, A., Navarro, P., Quin-
Imaging Facility at Whitehead Institute. J.Y. is a recipient of postdoc- tanilla, M., and Cano, A. (1993). Correlation of E-cadherin expression
toral fellowships from Damon Runyon Cancer Research Foundation, with differentiation grade and histological type in breast carcinoma.
NIH NRSA award (1 F32 CA101507) and the Margaret and Herman Am. J. Pathol. 142, 987–993.
Sokol Fellowship in Biomedical Research. S.A.M. is a recipient of
Gitelman, I. (1997). Twist protein in mouse embryogenesis. Dev.postdoctoral fellowship from US Army Breast Cancer Research Pro-
Biol. 189, 205–214.gram (DAMD17-01-1-0457). R.A.W. is an American Cancer Society
Gohji, K., Nakajima, M., Boyd, D., Dinney, C.P., Bucana, C.D., Kita-Research Professor and a Daniel K. Ludwig Cancer Research Pro-
zana, S., Kamidono, S., and Fidler, I.J. (1997). Organ-site depen-fessor. This research is supported by NIH grant R21-CA096689
dence for the production of urokinase-type plasminogen activator(R.A.W.), P01-CA80111 (R.A.W.), MIT/Ludwig Fund for Cancer Re-
and metastasis by human renal cell carcinoma cells. Am. J. Pathol.search (R.A.W.), and Harvard SPORE in Breast Cancer (A.R.).
151, 1655–1661.
Hajra, K.M., Chen, D.Y., and Fearon, E.R. (2002). The SLUG zinc-Received: September 30, 2003
finger protein represses E-cadherin in breast cancer. Cancer Res.Revised: March 1, 2004
62, 1613–1618.Accepted: May 3, 2004
Published: June 24, 2004 Hay, E.D. (1995). An overview of epithelio-mesenchymal transforma-
tion. Acta Anat. (Basel) 154, 8–20.
References Huiping, C., Sigurgeirsdottir, J.R., Jonasson, J.G., Eiriksdottir, G.,
Johannsdottir, J.T., Egilsson, V., and Ingvarsson, S. (1999). Chromo-
Acs, G., Lawton, T.J., Rebbeck, T.R., LiVolsi, V.A., and Zhang, P.J. some alterations and E-cadherin gene mutations in human lobular
(2001). Differential expression of E-cadherin in lobular and ductal breast cancer. Br. J. Cancer 81, 1103–1110.
neoplasms of the breast and its biologic and diagnostic implications.
Ip, Y.T., Park, R.E., Kosman, D., Yazdanbakhsh, K., and Levine, M.Am. J. Clin. Pathol. 115, 85–98.
(1992). dorsal-twist interactions establish snail expression in the
Aslakson, C.J., and Miller, F.R. (1992). Selective events in the meta- presumptive mesoderm of the Drosophila embryo. Genes Dev. 6,
static process defined by analysis of the sequential dissemination 1518–1530.
of subpopulations of a mouse mammary tumor. Cancer Res. 52,
Kang, Y., Siegel, P.M., Shu, W., Drobnjak, M., Kakonen, S.M., Cor-1399–1405.
don-Cardo, C., Guise, T.A., and Massague, J. (2003). A multigenic
Berx, G., Cleton-Jansen, A.M., Strumane, K., de Leeuw, W.J., Nollet, program mediating breast cancer metastasis to bone. Cancer Cell
F., van Roy, F., and Cornelisse, C. (1996). E-cadherin is inactivated 3, 537–549.
in a majority of invasive human lobular breast cancers by truncation
Leptin, M. (1991). twist and snail as positive and negative regulatorsmutations throughout its extracellular domain. Oncogene 13, 1919–
during Drosophila mesoderm development. Genes Dev. 5, 1568–1925.
1576.
Boyer, B., and Thiery, J.P. (1993). Epithelium-mesenchyme intercon-
Leptin, M., and Grunewald, B. (1990). Cell shape changes duringversion as example of epithelial plasticity. APMIS 101, 257–268.
gastrulation in Drosophila. Development 110, 73–84.
Bridge, A.J., Pebernard, S., Ducraux, A., Nicoulaz, A.L., and Iggo,
Miller, F.R. (1993). Immune mechanisms in the sequential steps ofR. (2003). Induction of an interferon response by RNAi vectors in
metastasis. Crit. Rev. Oncog. 4, 293–311.mammalian cells. Nat. Genet. 34, 263–264.
Moll, R., Mitze, M., Frixen, U.H., and Birchmeier, W. (1993). Differen-Carver, E.A., Jiang, R., Lan, Y., Oram, K.F., and Gridley, T. (2001).
tial loss of E-cadherin expression in infiltrating ductal and lobularThe mouse snail gene encodes a key regulator of the epithelial-
breast carcinomas. Am. J. Pathol. 143, 1731–1742.mesenchymal transition. Mol. Cell. Biol. 21, 8184–8188.
Castanon, I., and Baylies, M.K. (2002). A Twist in fate: evolutionary Muller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M.E.,
comparison of Twist structure and function. Gene 287, 11–22. McClanahan, T., Murphy, E., Yuan, W., Wagner, S.N., et al. (2001).
Involvement of chemokine receptors in breast cancer metastasis.Chen, Z.F., and Behringer, R.R. (1995). twist is required in head
Nature 410, 50–56.mesenchyme for cranial neural tube morphogenesis. Genes Dev.
9, 686–699. Ramaswamy, S., Ross, K.N., Lander, E.S., and Golub, T.R. (2003).
A molecular signature of metastasis in primary solid tumors. Nat.Clark, E.A., Golub, T.R., Lander, E.S., and Hynes, R.O. (2000). Geno-
Genet. 33, 49–54.mic analysis of metastasis reveals an essential role for RhoC. Nature
406, 532–535. Rosivatz, E., Becker, I., Specht, K., Fricke, E., Luber, B., Busch, R.,
Hofler, H., and Becker, K.F. (2002). Differential expression of theDroufakou, S., Deshmane, V., Roylance, R., Hanby, A., Tomlinson,
epithelial-mesenchymal transition regulators snail, SIP1, and twistI., and Hart, I.R. (2001). Multiple ways of silencing E-cadherin gene
in gastric cancer. Am. J. Pathol. 161, 1881–1891.expression in lobular carcinoma of the breast. Int. J. Cancer 92,
404–408. Signoretti, S., Di Marcotullio, L., Richardson, A., Ramaswamy, S.,
Isaac, B., Rue, M., Monti, F., Loda, M., and Pagano, M. (2002).Egeblad, M., and Werb, Z. (2002). New functions for the matrix
metalloproteinases in cancer progression. Nat. Rev. Cancer 2, Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast
cancer. J. Clin. Invest. 110, 633–641.161–174.
An Essential Role of Twist in Tumor Metastasis
939
Soo, K., O’Rourke, M.P., Khoo, P.L., Steiner, K.A., Wong, N., Beh-
ringer, R.R., and Tam, P.P. (2002). Twist function is required for the
morphogenesis of the cephalic neural tube and the differentiation
of the cranial neural crest cells in the mouse embryo. Dev. Biol.
247, 251–270.
Stewart, S.A., Dykxhoorn, D.M., Palliser, D., Mizuno, H., Yu, E.Y.,
An, D.S., Sabatini, D.M., Chen, I.S., Hahn, W.C., Sharp, P.A., et al.
(2003). Lentivirus-delivered stable gene silencing by RNAi in primary
cells. RNA 9, 493–501.
Thiery, J.P. (2002). Epithelial-mesenchymal transitions in tumour
progression. Nat. Rev. Cancer 2, 442–454.
Thisse, B., el Messal, M., and Perrin-Schmitt, F. (1987). The twist
gene: isolation of a Drosophila zygotic gene necessary for the estab-
lishment of dorsoventral pattern. Nucleic Acids Res. 15, 3439–3453.
van’t Veer, L.J., Dai, H., van de Vijver, M.J., He, Y.D., Hart, A.A.,
Mao, M., Peterse, H.L., van der Kooy, K., Marton, M.J., Witteveen,
A.T., et al. (2002). Gene expression profiling predicts clinical out-
come of breast cancer. Nature 415, 530–536.
